1 / 15

Lisa Harman CCFP-EM Candidate Resident Research Proposal Supervisor: Dr. Gatien

Lisa Harman CCFP-EM Candidate Resident Research Proposal Supervisor: Dr. Gatien Methodologist: Dr. Vaillancourt.

ray-dorsey
Download Presentation

Lisa Harman CCFP-EM Candidate Resident Research Proposal Supervisor: Dr. Gatien

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lisa Harman CCFP-EM Candidate Resident Research Proposal Supervisor: Dr. Gatien Methodologist: Dr. Vaillancourt The Treatment of Paroxysmal Supraventricular Tachycardia (PSVT) and the efficacy of calcium channel blockers verses adenosine in terminating this arrhythmia at The Ottawa Hospital.

  2. Background -PSVT (AVNRT and AVRT) is a common presentation to the ER department . -Current practice as per American Heart Association guidelines is adenosine by IV push. -Historically, however, the initial treatment was an IV bolus of verapamil. This was changed to the current recommendations by the 1992 guidelines due to hypotension from such treatment. -This was challenged by the 2009 RCT by Lim et al comparing the efficacy of IV adenosine to a slower infusion of calcium channel blockers. -They found that IV CCB was more efficacious, longer lasting in preventing rebound SVT and better tolerated. • Lim et al. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resus. 2009; 80: 523-528.

  3. Based on this RTC and the significant unpleasant sensation associated with the use of adenosine, CCB could be considered the treatment of choice in the ED for PSVT. I am interested to see the proportion of ED physicians at TOH that choose CCBs over adenosine

  4. Record Review • Conducting a retrospective record review of 100 charts with discharge Dx of PSVT, matching inclusion criteria to answer the study objectives….

  5. Objectives: • Primary Objective: To determine the treatment practices of the physicians at TOH- proportion of patients treated with adenosine vs. CCB.

  6. Objectives • Secondary Objectives • The success rate of adenosine vs. CCB in converting rhythm to sinus. • In the adenosine group, whether a second 12mg dose was needed • In the CCB group, whether a second higher infusion was need • In either group whether a second class of medication was needed to convert • Or in either group whether cardioversion was needed to convert due to pharmacological failure.

  7. Inclusion Criteria • Discharge Dx of PSVT(specifically AVNRT +/- orthodromic AVRT- excluding a.fib/flutter and MAT. ) • Stable (did not require immediate cardioversion)

  8. Exclusion Criteria • Arrhythmia converted spontaneously or with vagal maneuvers • Arrhythmia treated by EMS • Pregnancy on history • In context of decreased GCS, trauma or sepsis • Patients with an implanted pacemaker

  9. Table 1 Demographics:

  10. Primary Outcome

  11. Secondary Outcomes

  12. Secondary Outcomes * Side effects: hypotension, persistent asystole, a.fib, bronchospasm

  13. Next Steps: • REB approval • Design data collection tool • Design a study protocol

  14. References: • Orejarena LA, Vidaillet H Jr., DeStefano F, NordsteomDL, Vierkant RA, Smith PN, Hayes JJ. Paroxysmal supraventricular tachycardia in the general population. J Am Cardiol. 1998; 31 (1):150. • Trohman RG. Supraventricular tachycardia: Implications for the intensivist. Crit Care Med. 2000; 28 (10 Suppl):N129 • Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resus. 2009; 80: 523-528. • Neumar R, Otto C, Link M, Kronick S, Shuster M, Callaway C, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess, EP, Tang W, Davis D, Sinz E and Morrison LJ. Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circ. 2010; 122 S729-S767

  15. Questions/Suggestions?

More Related